Hong Yuan Holding Group (HGYN)
Zhengzhou, CN
Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until June 2021, when it officially adopted its current designation. Established in 2001, the entity's headquarters are situated in Zhengzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -20.63% | -14.91% | -29.41% | +76.99% | +57.89% | +14,900.00% | -25.00% | -72.73% | +2,900.00% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Shell Companies: +20.6%+241.1% ★ Q1'26: -81.9% (vs Q1'25)
-
EPS growth Shell Companies: -12.3%+261.5% ★ Q1'26: -360.0% (vs Q1'25)
-
FCF margin FCF growth · Shell Companies: +8.7%-7.1% Q1'26: -7.8% (vs Q1'25)
-
EBIT margin Shell Companies: +0.0%+21.1% ★ Q1'26: -216.4% (vs Q1'25)
-
ROIC Shell Companies: +0.0%+1,269.5% ★ Q1'26: +524.1% (vs Q1'25)
-
Share dilution Shell Companies: -10.2%+0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×0.06× ★ Q1'26: -0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IBC FUNDS, LLC | 28.87M | 8.67% | 28.87M | — | 28.87M | — | OO | Nevada | 2013-04-29 | ↗ |
| 2 | Management business group of UBS AG (see Item 7) | 17.44M | 6.80% | — | — | — | — | BK, HC | Switzerland | 2008-02-11 | ↗ |
| 3 | AQR Capital Management, LLC | 594.7K | 0.30% | — | 594.7K | — | 594.7K | IA | Delaware USA | 2013-02-21 | ↗ |
| 4 | 98-0186363 | 98.00 | 0.00% | — | — | — | — | BK, HC | Switzerland | 2011-02-04 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-03-02 | SCHEER FREDERIC | Officer | P-Purchase | A | Common Stock | 12,841 | — | — | 2,895,605 | — | ↗ |
| 2010-12-31 | McMURRAY MARGARET | Officer | — | D | Common stock | 0 | — | — | 4,708 | — | ↗ |
| 2010-12-31 | LARRIVEE GARY | Officer | — | D | Common Stock | 0 | — | — | 36,164 | — | ↗ |
| 2009-01-12 | KELLY WILLIAM E | Officer | P-Purchase | A | Common Stock | 237,152 | — | — | 1,409,652 | — | ↗ |
| 2009-01-12 | BAGRODIA SHRIRAM | Officer | P-Purchase | A | Common Stock | 175,202 | — | — | 281,041 | — | ↗ |
| 2008-09-30 | McMURRAY MARGARET | Officer | P-Purchase | A | Common Stock | 19,157 | — | — | 37,999 | — | ↗ |
| 2008-07-14 | Barton Mark | Officer | — | D | Common Stock | 0 | 0.00 | — | 538,376 | — | ↗ |
| 2007-07-02 | SCHEER FREDERIC | Officer | P-Purchase | A | Common Stock | 106,977 | — | — | 113,813,852 | — | ↗ |
| 2007-07-02 | GARDEN STEPHAN | Officer | P-Purchase | A | Common Stock | 68,575 | — | — | 1,520,344 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Xudong Li | CEO, President, Secretary & Director | — | male |
| Yanli Ma | Chief Financial Officer | — | female |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HGYN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
